ClinicalTrials.gg
RecruitingNCT07576751Updated Oct 29, 2026

Physiotherapy Practice in Flemish Nursing Homes

An observational study in Guideline Implementation, Physiotherapy and Nursing Homes, sponsored by Hasselt University. Recruiting at 4 sites in Belgium. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Hasselt University · Observational

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.
Updated Oct 29, 2026Site recruiting status changed1 site addedGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Sex
All
01

Study summary

The goal of this observational study is to evaluate the extent to which physiotherapy sessions in Flemish nursing homes adhere to the IAGG-GARN guidelines and to explore factors influencing clinical practice among physiotherapists.

The study targets multiple nursing homes across Flanders, with 3 to 5 centers in each of the provinces of Limburg, Antwerp, and Flemish Brabant. This selection ensures variation in geographic location and organizational context. The participants in this study are physiotherapists working in the participating nursing homes.

The main questions it aims to answer are:

  • To what extent do the physiotherapy sessions align with the IAGG-GARN guidelines?
  • Are there differences in physiotherapy session content and volume according to physiotherapist characteristics and resident characteristics?
  • What barriers and facilitators do physiotherapists experience when implementing guideline-based practice in Flemish nursing homes?

Researchers will observe physiotherapy sessions delivered as part of routine care and document session content and duration using structured observation diaries. Participating physiotherapists will also take part in focus groups discussing experiences with guideline implementation, barriers, facilitators, and clinical decision-making.

02

Conditions studied

  • Guideline Implementation
  • Physiotherapy
  • Nursing Homes
  • Focus Group

Keywords

  • Physical therapy
  • Older adults
  • Geriatrics
  • Long-term care
  • Guideline implementation
  • Focus groups
  • Clinical practice
03

In context

Lead sponsor

Hasselt University is the lead sponsor of 204 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of licensed physiotherapists working in Flemish nursing homes who provide physiotherapy to older residents

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • None beyond being a licensed physiotherapist working in a Flemish nursing home and willing to participate.

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Target follow-up
2 Weeks
Patient registry
Yes

Interventions

  • OtherMapping therapy sessions

    Mapping therapy sessions provided by physical therapists in Flemish nursing homes

06

What researchers measure

Primary outcomes

  1. Guideline Adherence to IAGG-GARN Recommendations

    Overall adherence of physiotherapy sessions in Flemish nursing homes to IAGG-GARN recommendations. Adherence is assessed through structured direct observation of the routine physiotherapy sessions. The secondary outcomes are operationalize adherence to the guideline (frequency, exercise intensity, exercise duration, exercise type and personalization)

    Time frame: 2 weeks

Secondary outcomes

  1. Exercise Description

    Narrative description of each exercise performed during a physiotherapy sessions.

    Time frame: 2 weeks

  2. Use of Equipment, Aids or Materials

    Type of equipment, aids or materials used during each exercise.

    Time frame: 2 weeks

  3. Exercise format

    Whether the exercise is performed individually or in a group setting.

    Time frame: 2 weeks

  4. Group Size

    Number of participants involved in group-based exercises.

    Time frame: 2 weeks

  5. Level of supervision

    Level of supervision provided by the physiotherapist during exercises (none, intermittent, continuous)

    Time frame: 2 weeks

  6. Exercise Start and End Time

    Start and end time of each exercise performed during physiotherapy sessions

    Time frame: 2 weeks

  7. Rest Periods During Exercises

    Rest periods during physiotherapy exercises, recorded separately as (1) rest periods instructed or allowed by the physiotherapist and (2) rest periods actually taken by the resident during exercise.

    Time frame: 2 weeks

  8. Exercise Category

    Category of each exercise performed during physiotherapy sessions (strength, endurance, mobility/flexibility, balance/coordination, or other)

    Time frame: 2 weeks

  9. Exercise Volume - Repetitions

    Number of repetitions per exercise, recorded separately as (1) repetitions prescribed by the physiotherapist and (2) repetitions actually performed by the resident during the exercise.

    Time frame: 2 weeks

  10. Exercise Intensity

    Intensity of each exercise performed during physiotherapy sessions, including whether intensity was explicitly determined during the exercise, the method used to determine intensity, the recorded intensity value, and the observer's interpretation (high, medium or low intensity).

    Time frame: 2 weeks

  11. Walking or Treadmill parameters

    Parameters during walking or treadmill exercises (incline and speed).

    Time frame: 2 weeks

  12. Cycling Parameters

    Parameters recorded during cycling exercises (rounds per minute, resistance and distance)

    Time frame: 2 weeks

  13. Speed of movement

    Speed of movement during exercises, classified according to the observed execution pace (slow, controlled or fast).

    Time frame: 2 weeks

  14. External Load (Resistance)

    External load applied during exercises (kg).

    Time frame: 2 weeks

  15. Contextual Factors

    Contextual elements influencing physiotherapy sessions, such as disturbances (e.g., noise, interruptions) and other relevant observations.

    Time frame: 2 weeks

Other outcomes

  1. Background information physiotherapists

    Age, gender, year of graduation, specialization, number of years of experience as a physiotherapist, educational level (e.g., bachelor, master…), employment regime (full-time, part-time, other appointment), number of years working within the nursing home and continuing education participation This information is pseudonymously linked to the observation data with the aim of identifying interpersonal differences in therapy approach.

    Time frame: baseline

  2. Background information residents

    In addition, the physiotherapeutic interventions will be linked to residents' background information to determine the extent to which the physiotherapists adapt their therapy to the specific needs of the patient. The following information will be used: * Age category: 65-70, 71-75, 76-80, 81-85, 86-90, 91-95, 96-100 and 100+ * Gender: male/female/other * Stable medical status: yes/no * Cognitive status (MMSE score): 25-30 (normal), 21-24 (mild cognitive impairment), 10-20 (moderate cognitive impairment), 0-9 (severe cognitive impairment) * Ability to walk (maximum achievable level for resident): independent, independent with walking aid, with assistance from caregiver, wheelchair-bound, bedridden * Ability to transfer (maximum achievable level for resident): independent, with aid, with assistance from caregiver, with hoist * Following physiotherapy: yes/no * Which (main) physiotherapist: physiotherapist ID * Type of stay: permanent residence/short-term stay * O or A profile: yes/no

    Time frame: baseline

  3. Focus groups with physiotherapists

    Step 1: Center-specific After completion of the observations, a center-specific feedback session will be held at each nursing home. These sessions (60-90 minutes, 2-8 therapists) present and discuss the results with physiotherapists, focusing on their work context, its influence on care delivery, and the reasoning behind their choices. Step 2: Validation Following the feedback sessions, a validation focus group will be organized at a neutral location (UHasselt), including 1-2 representatives per center and additional physiotherapists (10 participants, 60-90 minutes). Results from the observations and all feedback sessions will be presented anonymously. The discussion will focus on validating and deepening findings, identifying key themes and patterns, and determining priorities for further development Digital recordings of the focus groups will be made during the session. At the end of the focus groups, the recordings will be transcribed and anonymized for analysis.

    Time frame: 2 days

07

Study locations

3 of 4 sites recruiting
  • Nursing home
    Deurne, Antwerpen, Belgium
    Recruiting
  • Nursing home
    Zoersel, Antwerpen, Belgium
    Recruiting
  • Nursing home
    Tongeren, Limburg, Belgium
    Recruiting
  • Nursing home
    Hasselt, Belgium
    Not yet recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2026 (actual). Primary completion is estimated for Jan 2028, 21 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 2, 2026
First posted
May 8, 2026
StartActual
Mar 23, 2026
Primary completionEst.
Jan 1, 2028
CompletionEst.
Dec 1, 2028
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added. Nursing home is now Recruiting
Show site
  • Nursing home · Hasselt, Belgium
Oct 29, 2026
Secondary outcomes
1 description edited
What changed in the outcomes
  • Descriptionother outcomeBackground information residents: how it is measured was reworded
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    1 site added. Nursing home is now Recruiting
    Show site
    • Nursing home · Hasselt, Belgium
    Secondary outcomes 1 description edited
    What changed in the outcomes
    • Descriptionother outcomeBackground information residents: how it is measured was reworded
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07576751
Lead sponsor
Hasselt University
Responsible party
Joke Spildooren (Prof. dr., Hasselt University) — Principal investigator
First posted
May 8, 2026
Start date
Mar 23, 2026
Primary completion
Jan 1, 2028 (estimated)
Completion
Dec 1, 2028 (estimated)
Last update
Oct 29, 2026

Study contacts

Maxine Claes, Msc
Contact
maxine.claes@uhasselt.be
+3211268443
Joke Spildooren, Prof.dr
Contact
joke.spildooren@uhasselt.be
+3211269178
Joke Spildooren, Prof.dr
principal investigator · UHasselt

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion